ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,596Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 106

$924K Total Retail Price of All Prescriptions

Rank: 8 out of 106

790 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 790 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

39% of this provider’s 790 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

3% of this provider’s 5,548 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 59%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $178 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,509 505 S3 1 9
CARISOPRODOL 424 105 R 2 50
PROAIR HFA 344 170 3 3
FUROSEMIDE 321 192 4 7
LISINOPRIL 279 122 5 13
ZOLPIDEM TARTRATE 277 99 6 22
SPIRIVA 276 212 7 1
SIMVASTATIN 245 121 8 14
PREDNISONE 234 120 9 5
OMEPRAZOLE 221 81 10 10
LOSARTAN POTASSIUM 214 121 11 34
ADVAIR DISKUS 212 119 12 2
METFORMIN HCL 192 66 13 23
NEXIUM 176 110 14 28
SYMBICORT 147 64 15 4
VENTOLIN HFA 142 80 16 6
OXYCODONE HCL-ACETAMINOPHEN 139 55 S2 17 106
GABAPENTIN 133 39 18 27
POTASSIUM CHLORIDE 127 76 19 24
LEVOTHYROXINE SODIUM 124 66 20 17
CARVEDILOL 120 79 21 49
METOPROLOL TARTRATE 113 72 22 16
BYSTOLIC 111 43 23 119
METOPROLOL SUCCINATE 108 54 24 32
AMLODIPINE BESYLATE 107 62 25 19
CLONIDINE HCL 105 29 26 41
PROMETHAZINE HCL 97 26 R 27 82
ATORVASTATIN CALCIUM 97 63 27 30
AZITHROMYCIN 93 50 29 8
HYDROCHLOROTHIAZIDE 91 47 30 25
MORPHINE SULFATE ER 87 50 S2 31 152
WARFARIN SODIUM 84 64 32 21
CITALOPRAM HBR 75 30 33 31
SINGULAIR 75 54 33 11
LEVOFLOXACIN 75 48 33 20
DALIRESP 75 56 33 45
CIPROFLOXACIN HCL 74 33 37 48
ROPINIROLE HCL 73 38 38 39
DOXYCYCLINE HYCLATE 71 46 39 44
SERTRALINE HCL 66 20 40 35
MELOXICAM 61 39 41 46
RAMIPRIL 59 23 42 105
LYRICA 58 31 43 100
TAMSULOSIN HCL 56 34 44 52
TRAZODONE HCL 55 23 45 51
ALPRAZOLAM 52 45 46 187
GLIPIZIDE ER 51 28 47 193
PRAVASTATIN SODIUM 50 18 48 33
HYDROMORPHONE HCL 50 14 S2 48 194
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.